Zoetis Inc. (ZTS): Share Repurchases
$3.23B
Year ended 2025-12-31
$3.64B
Trailing 12 months to 2026-06-30
+26.6%
3-year compound annual growth
+66.9%
5-year compound annual growth
+31.9%
10-year compound annual growth
| Period ended | Share Repurchases | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $3.23B | +74.1% | 2026-02-12, From 2025-01-01 |
| 2024-12-31 | $1.86B | +70.1% | 2026-02-12, From 2024-01-01 |
| 2023-12-31 | $1.09B | -31.5% | 2026-02-12, From 2023-01-01 |
| 2022-12-31 | $1.59B | +114.5% | 2025-02-13, From 2022-01-01 |
| 2021-12-31 | $743.00M | +197.2% | 2024-02-13, From 2021-01-01 |
| 2020-12-31 | $250.00M | -60.1% | 2023-02-14, From 2020-01-01 |
| 2019-12-31 | $626.00M | -10.3% | 2022-02-15, From 2019-01-01 |
| 2018-12-31 | $698.00M | +39.6% | 2021-02-16, From 2018-01-01 |
| 2017-12-31 | $500.00M | +66.7% | 2020-02-13, From 2017-01-01 |
| 2016-12-31 | $300.00M | +47.8% | 2019-02-14, From 2016-01-01 |
| 2015-12-31 | $203.00M | n/a | 2018-02-15, From 2015-01-01 |
| 2014-12-31 | $0 | n/a | 2017-02-16, From 2014-01-01 |
| 2013-12-31 | $0 | n/a | 2016-02-24, From 2013-01-01 |
Share Repurchases at similar companies
| Company | Year ended | Share Repurchases | Change YoY |
|---|---|---|---|
| Zoetis Inc. (ZTS) | 2025-12-31 | $3.23B | +74.1% |
| Vertex Pharmaceuticals Inc (VRTX) | 2025-12-31 | $2.02B | +71.4% |
| Viatris Inc (VTRS) | 2025-12-31 | $500.50M | +100.2% |
| Regeneron Pharmaceuticals, Inc. (REGN) | 2025-12-31 | $3.44B | +32.1% |
| Jazz Pharmaceuticals plc (JAZZ) | 2025-12-31 | $125.02M | -59.9% |
| United Therapeutics Corp (UTHR) | 2025-12-31 | $1.00B | 0.0% |
| Royalty Pharma plc (RPRX) | 2025-12-31 | $1.23B | +434.5% |
| Sarepta Therapeutics, Inc. (SRPT) | 2025-12-31 | $25.01M | n/a |
| Abbott Laboratories (ABT) | 2025-12-31 | $893.00M | -31.0% |
Compare ZTS, VRTX, VTRS, REGN side by side · Screen every company in Pharmaceutical Preparations ↗